Clinical Trial Update: Effects of SGLT-2 Inhibition on Hepatic Glucose and Energy Metabolism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining the effects of SGLT-2 inhibition on hepatic glucose metabolism in individuals with Type 2 diabetes mellitus and metabo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Medical University of Vienna | Conditions: Type 2 Diabetes, Metabolically Healthy Controls | Phase 2 | Status: UNKNOWN